Thursday, January 16, 2014
Publication and contact
Synthetic, homogenous erythropoietin (EPO)
Solid-phase synthesis of
homogenous, glycosylated EPO could lead to synthetic approaches for
manufacture of biologics. Four oligosaccharides were synthesized and attached
to peptide fragments obtained by solid-phase peptide synthesis. The
glycosylated peptides were assembled by chemical ligation to yield homogenous
EPO with one O-linked and three N-linked glycans. After assembly, EPO was
folded. In a cultured, bone marrow-derived cell line and in mice, synthetic
EPO exhibited activity comparable to Procrit. Next steps include
synthesis of mutant proteins with oncogenic properties.
& Johnson markets Procrit recombinant EPO to treat
Published online Jan. 16, 2014
Patent pending; available
Wang, P. et al. Science;
published online Dec. 13, 2013;
Contact: Samuel J. Danishefsky, Sloan Kettering Institute, Memorial
Sloan Kettering Cancer Center, New York, N.Y.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]